z-logo
open-access-imgOpen Access
Immunological treatment of liver tumors
Author(s) -
Maurizio ChirivaInternati,
Fabio Grizzi,
Cynthia Jumper,
Everardo Cobos,
Paul L. Hermonat,
Eldo E Frezza
Publication year - 2005
Publication title -
world journal of gastroenterology
Language(s) - Uncategorized
Resource type - Journals
SCImago Journal Rank - 1.427
H-Index - 155
eISSN - 2219-2840
pISSN - 1007-9327
DOI - 10.3748/wjg.v11.i42.6571
Subject(s) - immunotherapy , medicine , genetic enhancement , immune system , antigen , liver cancer , chemotherapy , cancer research , immunology , gene , biology , hepatocellular carcinoma , biochemistry
Although multiple options for the treatment of liver tumors have often been described in the past, including liver resection, radiofrequency ablation with or without hepatic pump insertion, laparoscopic liver resection and the use of chemotherapy, the potential of immunotherapy and gene manipulation is still largely unexplored. Immunological therapy by gene manipulation is based on the interaction between virus-based gene delivery systems and dendritic cells. Using viruses as vectors, it is possible to transduce dendritic cells with genes encoding tumor-associated antigens, thus inducing strong humoral and cellular immunity against the antigens themselves. Both chemotherapy and radiation therapy have the disadvantage of destroying healthy cells, thus causing severe side-effects. We need more precisely targeted therapies capable of killing cancer cells while sparing healthy cells. Our goal is to establish a new treatment for solid liver tumors based on the concept of cytoreduction, and propose an innovative algorithm.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here